CoChat

Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature

Open access

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Background.: Noninvasive biomarkers distinguishing early immune activation before acute rejection (AR) could more objectively inform immunosuppression management in liver transplant recipients (LTRs). We previously reported a genomic profile distinguishing LTR with AR versus stable graft function. This current study includes key phenotypes with other causes of graft dysfunction and uses a novel random forest approach to augment the specificity of predicting and diagnosing AR. Methods.: Gene expression results in LTRs with AR versus non-AR (combination of other causes of graft dysfunction and normal function) were analyzed from single and multicenter cohorts. A 70:30 approach (61 ARs; 162 non-ARs) was used for training and testing sets. Microarray data were normalized using a LT-specific vector. Results.: Random forest modeling on the training set generated a 59-probe classifier distinguishing AR versus non-AR (area under the curve 0.83; accuracy 0.78, sensitivity 0.70, specificity 0.81, positive predictive value 0.54, negative predictive value [NPV] 0.89; F-score 0.61). Using a locked threshold, the classifier performed well on the testing set (accuracy 0.72, sensitivity 0.67, specificity 0.73, positive predictive value 0.48, NPV 0.86; F-score 0.56). Probability scores increased in samples preceding AR versus non-AR, when liver function tests were normal, and decreased following AR treatment (P < 0.001). Ingenuity pathway analysis of the genes revealed a high percentage related to immune responses and liver injury. Conclusions.: We have developed a blood-based biologically relevant biomarker that can be detected before AR-associated graft injury distinct from LTR never developing AR. Given its high NPV (“rule out AR”), the biomarker has the potential to inform precision-guided immunosuppression minimization in LTRs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/tp.0000000000003895

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1. The ROCs—AR vs non-AR. The AUC is displayed as well as the performance characteristics (25% AR prevalence adjustment) at the 0.34 threshold. AR, acute rejection; AUC, area under the curve; ROC, receiver operating curve.
FIGURE 1. The ROCs—AR vs non-AR. The AUC is displayed as well as the performance characteristics (25% AR prevalence adjustment) at the 0.34 threshold. AR, acute rejection; AUC, area under the curve; ROC, receiver operating curve.CC BY-NC-ND · PubMed Central
FIGURE 2. Serial changes in AR vs non-AR gene expression scores using line slopes. A, Pre-AR vs pre–non-AR (P = 0.0002). B, Pre-AR vs post-AR (P = 0.0001). AR, acute rejection.
FIGURE 2. Serial changes in AR vs non-AR gene expression scores using line slopes. A, Pre-AR vs pre–non-AR (P = 0.0002). B, Pre-AR vs post-AR (P = 0.0001). AR, acute rejection.CC BY-NC-ND · PubMed Central
FIGURE 3. Three-dimensional principal component analysis score plots for sample clustering, using 59 probes from the random forest classifier between AR and non-AR. The left plot is for training (n = 156) and the right plot is for testing (67) sample sets. AR, acute rejection.
FIGURE 3. Three-dimensional principal component analysis score plots for sample clustering, using 59 probes from the random forest classifier between AR and non-AR. The left plot is for training (n = 156) and the right plot is for testing (67) sample sets. AR, acute rejection.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 69 references

Cited by

See all 36

Metadata

Authors
Levitsky, J., Kandpal, M., Guo, K., Zhao, L., Kurian, S., Whisenant, T., & Abecassis, M.
Affiliations
  • Northwestern University (US)
  • Scripps Green Hospital (US)
  • University of California San Diego (US)
  • University of Arizona (US)
Corresponding author
Levitsky, Josh
Venue
Transplantation
Published
2021-07-22
Volume
106
Issue
5
Pages
1004-1011
ISSN
0041-1337 (ISSN-L)
OpenAlex
W3185370477
Cited by
36
References
69
Citations by year
2026: 6 · 2025: 7 · 2024: 4 · 2023: 5 · 2022: 10 · 2021: 2
FWCI
4.93
Type
journal article
Language
en
Open access
Locations
  • Transplantation (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (U01AI084146)
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords
liver transplant rejection, acute rejection, gene expression signatures, random forest, non-invasive biomarkers, graft dysfunction, immunosuppression management, blood-based biomarkers, liver injury, immune response genes, Ingenuity Pathway Analysis
MeSH terms
Graft Rejection, Humans, Postoperative Complications, Biomarkers, Kidney Transplantation, Liver Transplantation, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature. https://app.cochat.ai/papers/10.1097/tp.0000000000003895
The paper
Levitsky, J., Kandpal, M., Guo, K., Zhao, L., Kurian, S., Whisenant, T., & Abecassis, M. (2022). Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature. Transplantation. https://doi.org/10.1097/tp.0000000000003895

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.